4.6 Article

Correlation between CD16a binding and immuno effector functionality of an antigen specific immunoglobulin Fc fragment (Fcab)

Journal

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 526, Issue 2, Pages 154-158

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2012.05.010

Keywords

Antibody; Immunoglobulin; Fc fragment; Fc receptor binding; CD16a; CD64; ADCC

Funding

  1. f-star GmbH
  2. Christian Doppler Forschungsgesellschaft

Ask authors/readers for more resources

Antigen binding immunoglobulin Fc fragments (Fcab) are generated by engineering loop regions in the CH3 domain of human IgG1 Fc. Variants of an Fcab specific for Her-2 were designed to display either enhanced (S239D:A330L:I332E) or diminished (L234A:L235A) binding affinities to the Fc receptor CD16a based on mutations described previously. The two mutant Fcab proteins demonstrated the expected modulation of CD16a binding. Interaction with recombinant or cell surface expressed Her-2 was unaffected in both mutants compared to the parental Fcab. Binding affinities for CD16a correlated with the ADCC-potencies of the Fcab variants. Additional studies indicated that the L234A:L235A variant Fcab had equivalent structural features as the unmodified Fcab since their DSC profiles were similar and antigen binding after re-folding upon partial heat denaturation had not changed. Introduction of the S239D:A330L:I332E mutations resulted in a significant reduction of the CH2 domain melting temperature, a moderate decrease of the thermal transition of the CH3 domain and lower antigen binding after thermal stress compared to the parental Fcab. We conclude that the known correlation between CD16a binding affinity and ADCC potency is also valid in Fcab proteins and that antigen specific Fcab molecules can be further engineered for fine tuning of immuno effector functions. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Nanoscience & Nanotechnology

Fab antibody fragment-functionalized liposomes for specific targeting of antigen-positive cells

Anna Ohradanova-Repic, Eugenia Nogueira, Ingrid Hartl, Andreia C. Gomes, Ana Preto, Eva Steinhuber, Vanessa Muehlgrabner, Marko Repic, Mario Kuttke, Alexander Zwirzitz, Marek Prouza, Miloslav Suchanek, Gordana Wozniak-Knopp, Vaclav Horejsi, Gernot Schabbauer, Artur Cavaco-Paulo, Hannes Stockinger

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Article Multidisciplinary Sciences

An antibody with Fab-constant domains exchanged for a pair of CH3 domains

Gordana Wozniak-Knopp, Gerhard Stadlmayr, Jan Walther Perthold, Katharina Stadlbauer, Mathias Gotsmy, Stefan Becker, Florian Rueker

PLOS ONE (2018)

Article Biochemistry & Molecular Biology

Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies

Sylvia Dietrich, Alec W. Gross, Stefan Becker, Bjorn Hock, Gerhard Stadlmayr, Florian Ruker, Gordana Wozniak-Knopp

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)

Article Biochemistry & Molecular Biology

Stabilization of soluble high-affinity T-cell receptor with de novo disulfide bonds

Flavio Sadio, Gerhard Stadlmayr, Katharina Stadlbauer, Maximilian Graef, Agnes Scharrer, Florian Rueker, Gordana Wozniak-Knopp

FEBS LETTERS (2020)

Article Cell Biology

An engineered CD81-based combinatorial library for selecting recombinant binders to cell surface proteins: Laminin binding CD81 enhances cellular uptake of extracellular vesicles

Stefan Vogt, Madhusudhan Reddy Bobbili, Gerhard Stadlmayr, Katharina Stadlbauer, Jorgen Kjems, Florian Ruker, Johannes Grillari, Gordana Wozniak-Knopp

Summary: Research has shown that by using the CD81 protein to recognize target antigens, the targeted delivery capability of EVs can be enhanced, and this has been validated in mammalian cells. Mutant sequences are reformatted into full-length CD81 and expressed in EVs produced by HeLa cells, showing improved uptake by specific antigens.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Biochemistry & Molecular Biology

Trispecific antibodies produced from mAb(2) pairs by controlled Fab-arm exchange

Veronica Natale, Gerhard Stadlmayr, Filippo Benedetti, Katharina Stadlbauer, Florian Ruker, Gordana Wozniak-Knopp

Summary: Bispecific antibodies and antibody fragments have increasing importance in clinical applications for enhanced targeting selectivity and modulation of multiple cellular pathways. In this study, symmetrical bispecific parental antibodies were engineered to guide the formation of a controlled trispecific antibody with minimal point mutations. The resulting molecules exhibited good biophysical characteristics and retained the antigen reactivity and biological activity of the parental constructs.

BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Bispecific T-Cell Engagers Targeting Membrane-Bound IgE

Aleksandra Rodak, Gerhard Stadlmayr, Katharina Stadlbauer, Dominic Lichtscheidl, Madhusudhan Reddy Bobbili, Florian Rueker, Gordana Wozniak-Knopp

Summary: The study of IgE is important in the treatment of allergies and asthma, and therapeutic anti-IgE antibodies can intervene in its function by different mechanisms to reduce serum IgE levels. Bispecific antibody fusion proteins have shown promising results in eliciting cytotoxic T-cell-mediated killing through specific activation.

BIOMEDICINES (2021)

Article Biology

A Tetravalent Biparatopic Antibody Causes Strong HER2 Internalization and Inhibits Cellular Proliferation

Filippo Benedetti, Katharina Stadlbauer, Gerhard Stadlmayr, Florian Rueker, Gordana Wozniak-Knopp

Summary: This study constructed a novel antibody by combining two different monoclonal antibodies, leading to a rapid reduction in surface receptor levels of HER2-positive cells and demonstrating a specific anti-proliferative effect in vitro against these cells.

LIFE-BASEL (2021)

Article Biochemistry & Molecular Biology

Bispecific mAb2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab

Katharina Stadlbauer, Peter Andorfer, Gerhard Stadlmayr, Florian Ruker, Gordana Wozniak-Knopp

Summary: Inhibition of complement activation by overexpressing complement-regulatory proteins can disguise cancer cells from the immune system, but may also reduce the efficacy of therapeutic antibodies. By selecting CD59-specific Fc fragments, a bispecific antibody was created that can induce higher specific cytotoxicity at a lower concentration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Development of a Cytotoxic Antibody-Drug Conjugate Targeting Membrane Immunoglobulin E-Positive Cells

Aleksandra Rodak, Katharina Stadlbauer, Madhusudhan Reddy Bobbili, Oskar Smrzka, Florian Rueker, Gordana Wozniak Knopp

Summary: This study developed an antibody-drug conjugate that showed cytotoxicity for IgE-positive cells. The antibody had fast internalization and strict target specificity, providing a valuable starting point for the development of an anti-IgE cell-depleting agent.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains

Filippo Benedetti, Florian Stracke, Gerhard Stadlmayr, Katharina Stadlbauer, Florian Ruker, Gordana Wozniak-Knopp

Summary: Monoclonal antibodies can be engineered to have high affinity binding to two target antigens by introducing multiple binding sites through C(H)3 domain modifications. The bispecific antibodies with exchanged antigen-binding C(H)3 domains showed expected molecular composition, high expression levels, and retained high thermostability in laboratory conditions. These antibodies offer an alternative solution in positioning and valency of antigen binding sites.

BIOCHEMISTRY AND BIOPHYSICS REPORTS (2021)

Article Medicine, Research & Experimental

Beyond affinity: selection of antibody variants with optimal biophysical properties and reduced immunogenicity from mammalian display libraries

Michael R. Dyson, Edward Masters, Deividas Pazeraitis, Rajika L. Perera, Johanna L. Syrjanen, Sachin Surade, Nels Thorsteinson, Kothai Parthiban, Philip C. Jones, Maheen Sattar, Gordana Wozniak-Knopp, Florian Rueker, Rachael Leah, John McCafferty

Article Biochemistry & Molecular Biology

Activation of the TGF-81/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells

Yuri Nagaoka, Kotone Oshiro, Yuta Yoshino, Toshiyuki Matsunaga, Satoshi Endo, Akira Ikari

Summary: This study investigated the effect of intercellular adhesion molecule CLDN1 on the anticancer drug sensitivity of small-cell lung cancer (SCLC) cells. It was found that overexpression of CLDN1 decreased the sensitivity of SCLC cells to anticancer drugs and enhanced their migratory capacity through the activation of the TGF-81/EMT signaling pathway. Treatment with EMT inhibitors showed potential in overcoming the reduced sensitivity to anticancer drugs in CLDN1-overexpressing SCLC cells.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2024)